Next-Generation Dexcom G7 Continuous Glucose Monitoring System Now Available in Canada

Dexcom G7 is available for people with all types of diabetes ages two years and older, giving more Canadians than ever access to a simple, accurate1 and effective diabetes management solution

BURNABY, British Columbia--(BUSINESS WIRE)-- Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced today that its next-generation Dexcom G7 Continuous Glucose Monitoring (CGM) System will be available on October 10, 2023, for Canadians living with all types of diabetes ages two and older, including those who are pregnant. Its introduction brings the most accurate CGM on the market*,1 to Canadians, offering users a new way to gain greater control of their diabetes.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231005024203/en/

Dexcom G7 offers Canadians a better way to manage their diabetes, with insightful health information available at a glance, empowering them to make informed decisions. For a list of compatible devices, visit dexcom.com/compatibility. (Photo: Business Wire)

“CGM has become the standard of care for diabetes management for good reason,” said André Côté, Vice President and General Manager, Dexcom Canada. “We strongly believe that Canadians who are now able to access Dexcom G7 CGM will immediately benefit from the improved accuracy and easy-to-adopt user experience, while finding comfort in the trusted technology that Dexcom has pioneered. Our top priority will always be to empower those living with diabetes to make more insightful decisions about food, activity, and treatment in a simple and effective way, and Dexcom G7 allows us to achieve that with more impact than ever before.”

As diabetes continues to be one of the most common chronic conditions affecting people in Canada2, the need for more effective and easy-to-use technology has become increasingly important. Dexcom G7 is designed to take the guesswork out of managing diabetes. It offers users the ability to see their glucose levels and where they’re headed at a glance, enabling them to make smarter decisions in the moment to take better control of their diabetes. For a condition like diabetes that is ever-changing and can be unpredictable, CGM is a valuable tool for individuals and families to manage health with confidence.

Engineered with comfort and simplicity in mind, Dexcom G7 is the most accurate CGM system available*,1 and is clinically proven to lower A1C and reduce hypoglycemic events3-8.

Key Features of the Dexcom G7 CGM System:

• Easy to wear - the smallest Dexcom sensor ever that can be worn comfortably and discreetly
• Easy to insert - simple, painless †,9 one-push applicator with all-in-one sensor – no assembly required
• Easy to start: 96% of users said Dexcom G7 was easy to use9
• Fast sensor warm-up time (only 30 minutes)
• Real-time glucose readings are sent automatically to a compatible display device‡
• No routine finger sticks§, scanning, or calibration required
• Easy to personalize alerts to match a user’s lifestyle and needs
• A predictive alert that alerts users up to 20 minutes in advance of severe hypoglycemia (